Haloperidol for the Treatment of Nausea and Vomiting in the ED

Summary

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of nausea or vomiting. A total of 300 patients age 18-55 presenting to the emergency department with chief complaint of nausea or vomiting will be enrolled from February 2021 - February 2022. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Timeline

Start

2021-04-01

Primary completion

2023-05-22

Completion

2023-05-22

Drugs

Indications

No indication recorded.